ArticleAmerican journal of cancer research2025

Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer among young women (≤35): a retrospective cohort study based on SEER database and TJMUCH registry.

Mengjun Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.